The University of Chicago Header Logo

Connection

Richard A. Larson to Thalidomide

Back to Details
This is a "connection" page, showing publications Richard A. Larson has written about Thalidomide.
Richard A. Larson
Connection Strength
0.026
Thalidomide
  1. A randomized, double-blind, placebo-controlled phase 2 study evaluating the efficacy and safety of romiplostim treatment of patients with low or intermediate-1 risk myelodysplastic syndrome receiving lenalidomide. J Hematol Oncol. 2012 Nov 29; 5:71.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.